ESR1 and breast carcinoma: However, detailed in vitro studies using human breast cancer cell lines with different ERα expression status show that ORAI3 expression is ERα sensitive and that ORAI3 levels are greater in ERα-positive breast cancer cell lines compared to those that are ERα-negative [29,30].